Trevi Therapeutics Inc (TRVI)
2.92
+0.28
(+10.61%)
USD |
NASDAQ |
May 09, 16:00
2.92
0.00 (0.00%)
After-Hours: 20:00
Trevi Therapeutics Total Assets (Quarterly): 89.40M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 89.40M |
September 30, 2023 | 95.90M |
June 30, 2023 | 100.98M |
March 31, 2023 | 116.20M |
December 31, 2022 | 123.02M |
September 30, 2022 | 128.36M |
June 30, 2022 | 81.41M |
March 31, 2022 | 30.39M |
December 31, 2021 | 38.48M |
September 30, 2021 | 31.60M |
June 30, 2021 | 39.15M |
Date | Value |
---|---|
March 31, 2021 | 42.86M |
December 31, 2020 | 47.13M |
September 30, 2020 | 55.88M |
June 30, 2020 | 47.01M |
March 31, 2020 | 54.24M |
December 31, 2019 | 60.00M |
September 30, 2019 | 66.02M |
June 30, 2019 | 75.12M |
March 31, 2019 | 17.18M |
December 31, 2018 | 10.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
30.39M
Minimum
Mar 2022
128.36M
Maximum
Sep 2022
69.64M
Average
60.00M
Median
Dec 2019
Total Assets (Quarterly) Benchmarks
Accuray Inc | 462.53M |
Vanda Pharmaceuticals Inc | 648.44M |
NovaBay Pharmaceuticals Inc | 9.034M |
Palatin Technologies Inc | 13.55M |
iBio Inc | 34.02M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 6.856M |
Shareholders Equity (Quarterly) | 82.55M |